Self-Care for Lymphedema in Patients With Breast Cancer

NCT00670644 | Completed

• 4 other identifiers: CDR0000587714P30CA068485VU-VICC-SUPP-0628VU-VICC-060480
• Study Type: observational
• Target: 51
• Locations: 1 country
• Sites: 3

Brief Summary

RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment. PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.

Conditions

Breast Cancer

Keywords

male breast cancer; recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer

Outcome Measures

Primary Outcomes (3)

• Identification and description of barriers to completing recommended at home self-care of lymphedema

  one time only for approximately 15 minutes

• Identification of patients recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others

  one time only for approximately 15 minutes

• Identification of current at home self-care practices for lymphedema

  one time only for approximately 15 minutes

Secondary Outcomes (2)

• Relationship between at home self-care activities, symptoms, and quality of life in breast cancer survivors with lymphedema

  one time only for approximately 15 minutes

• Identification of patient-perceived benefits to at home self-care

  one time only for approximately 15 minutes

Interventions

questionnaire administration OTHER

Completed self-report form

survey administration OTHER

Completed self-report form-other

quality-of-life assessment PROCEDURE

Completed self-report form qol

Eligibility Criteria

• Age: 18 Years - 120 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Breast Cancer patients

DISEASE CHARACTERISTICS: * History of breast cancer * Lymphedema in one or both arms that occurred during or after breast cancer treatment * Must have received prior lymphedema treatment by a healthcare professional * Patients with self-reported arm swelling subsequent to breast cancer treatment that has not been treated by a healthcare professional are not eligible * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Menopausal status not specified * English speaking PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Vanderbilt University: lead
• National Cancer Institute (NCI): collaborator

Study Sites (3)

Vanderbilt-Ingram Cancer Center - Cool Springs

Nashville, Tennessee, 37064, United States

Location

Vanderbilt-Ingram Cancer Center at Franklin

Nashville, Tennessee, 37064, United States

Location

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, 37232-6838, United States

Location

MeSH Terms

Conditions

Breast Neoplasms; Breast Neoplasms, Male

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Shiela H. Ridner, MSN, PhD, RN

  Vanderbilt-Ingram Cancer Center

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: May 1, 2008
• First Posted: May 2, 2008
• Study Start: May 1, 2006
• Primary Completion: May 1, 2007
• Study Completion: March 1, 2011
• Last Updated: April 10, 2017

Record last verified: 2017-04

Locations

US (3)